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ABSTRACT
The prevalence and associated factors of chronic uncomplicated strongyloidiasis were estimated among
200 consecutive elderly patients (aged ‡ 60 years) admitted to a general hospital in northern Italy. One-
hundred patients had a peripheral eosinophil concentration ‡ 500 cells ⁄ lL (group A), and 100 were age-
and gender-matched controls (group B). Measurements included serum IgG anti-Strongyloides antibody
titre by an indirect immunofluorescence assay, combined with faecal culture for Strongyloides stercoralis.
Anti-Strongyloides antibodies were detected in 28 patients (at high titre in 11 patients). Seropositivity was
significantly more common among group A than among group B patients (OR 4.85). Strong
seropositivity for anti-Strongyloides antibodies was associated with farm work (p < 0.001), but not with
other patient characteristics or with signs and symptoms of strongyloidiasis. In conclusion, strongylo-
idiasis was relatively common among elderly in-patients; eosinophilia and a history of farm work were
the most useful indications for this diagnosis.
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INTRODUCTION
Strongyloidiasis is a parasitic disease caused by
two species of intestinal nematodes, of which
Strongyloides stercoralis is by far the most import-
ant clinically [1–3]. Infection by S. stercoralis
usually results in chronic disease of the gut
(uncomplicated infection), which can remain
undetected for decades. The most common clin-
ical findings reported in patients with uncompli-
cated infection include mild-to-moderate
eosinophilia, skin lesions, gastrointestinal com-
plaints (diarrhoea, abdominal pain) and respirat-
ory symptoms (cough, asthma). Most of the
literature concerning strongyloidiasis derives
from retrospective reviews of the clinical records
of patients, making it difficult to attribute a
correct diagnostic value to each of these findings.
Approximately one-third of patients are asymp-
tomatic [4].
Under certain circumstances, parasite dissem-
ination and ⁄ or hyper-infection may occur; this is
often unrecognised and can be rapidly fatal.
Typically, these complicated forms of strongylo-
idiasis occur following immunosuppression [5],
often because of corticosteroid therapy or haem-
atological malignancies, with the affected patients
being elderly and hospitalised. According to
recently issued guidelines [6], screening for
asymptomatic strongyloidiasis is indicated for
patients who have unexplained peripheral eosi-
nophilia, or who have resided in or travelled to
areas endemic for strongyloidiasis (i.e., tropical
and sub-tropical regions of the world and the
southern USA), even during the distant past.
Patients who have never travelled to or resided in
areas recognised as endemic are not considered to
be at risk, although reliable and updated preval-
ence data are absent for many countries [7].
The aim of the present study was to investigate
the seroprevalence of strongyloidiasis among
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elderly patients hospitalised in a rural area of
northern Italy, and to verify prospectively the
value of certain characteristics (e.g., eosinophilia,
working history, signs and symptoms of strong-
yloidiasis) that might help to raise suspicion for a
diagnosis of uncomplicated strongyloidiasis.
MATERIALS AND METHODS
Setting
The province of Novara in the north-west of Italy is an area of
1339 km2, with 322 km2 occupied by rice fields with an annual
rice production of c. 200 000 tonnes. The climate is temperate,
with a highest mean daily temperature between August 2002
and July 2003 of 31.4C, a lowest temperature of 1.0C, and
annual rainfall of 800 mm. Novara Maggiore della Carita`
Hospital is a 717-bed acute-care general hospital serving a
population of c. 344 000, of whom 26.4% are aged ‡ 60 years.
The most recent epidemiological data, dating back to the late
1980s, indicated that strongyloidiasis was endemic in this area
[8].
Patients
Cases and controls were identified prospectively from the
computerised record system of the Laboratory of Clinical
Pathology for 40 days during a 6-month period between 16
September 2002 and 17 March 2003. Search criteria were an
eosinophil count ‡ 0.5 · 109 ⁄L, an age ‡ 60 years, and hospi-
talisation as an in-patient. Among 17 174 results scrutinised,
288 (1.68%) from 256 patients showed an eosinophil count
‡ 0.5 · 109 ⁄L. Of these, 156 were either outpatients, or
patients who died or were discharged within 24 h of admis-
sion. The remaining 100 patients (group A) were contacted in
their hospital ward on the same day and were asked to give
informed consent to participate in the study and to answer a
questionnaire administered by one of the authors (ES). The
questionnaire requested details regarding each patient’s
employment history, and in particular, whether the patient
had worked in farms and ⁄or in rice fields, and the presence or
absence of pruritus, skin lesions, recurrent abdominal pain and
respiratory symptoms (chronic cough, asthma). Controls
(group B) were 100 individually age- (± 2.5 years) and gen-
der-matched patients admitted to the same hospital ward as
the corresponding case, but who had an eosinophil count
< 0.5 · 109 ⁄L. Group B patients were also requested to give
informed consent and to answer the same questionnaire. The
study was conducted in strict accordance with the principles of
the Helsinki Declaration.
Plasma samples for S. stercoralis serology were obtained by
centrifugation of blood samples remaining after clinically
indicated tests had been completed. Plasma aliquots were kept
frozen at ) 30C for £ 9 months before further processing.
S. stercoralis serology
IgG antibodies against S. stercoralis were detected by an
indirect immunofluorescence assay developed and validated
at the Centre for Tropical Diseases, Sacro Cuore Hospital,
Negrar-Verona by two of the authors (MG, ZB). In brief,
filariform larvae were isolated from fresh stool samples by the
Baermann technique. The material obtained was washed five
times in phosphate-buffered saline pH 7.2 at 4C, exposed to
cold acetone for 30 min, re-washed with phosphate-buffered
saline, passed through a 14-mm filter and applied to glass
coverslips. Study samples (25 lL), at an initial dilution of 1:20,
were added to the coverslips in duplicate and incubated at
37C for 30 min. After being rinsed twice with phosphate-
buffered saline, the coverslips were incubated for 30 min at
37C with 25 lL of 1:50 fluorescein isothiocyanate-conjugated
anti-human IgG containing Evans blue 0.2% v ⁄v (bioMe´rieux,
Rome, Italy). After extensive washing, specimens were embed-
ded in Fluoroprep (bioMe´rieux) and were viewed on a Leitz
Laborlux S fluorescence microscope by an experienced micro-
biologist who was unaware of the clinical data.
The diagnostic value of the above assay was validated by
testing blood samples from 122 patients with culture-proven
S. stercoralis infestation and from 229 healthy blood donors. At
sample dilutions > 1:80, the sensitivity and specificity for a
diagnosis of strongyloidiasis were 63% and 100%, respectively.
Faecal cultures
For each patient, three fresh stool specimens, obtained in the
morning on different days and processed within 5 h, were
plated on Mueller–Hinton agar and incubated at 26–30C for
‡ 3 days. The culture plates were then evaluated by a single
experienced microbiologist (CG). Samples in which either
rhabditiform or filariform larvae, or channels carved into the
agar by the parasite, were identified were considered to be
positive.
Treatment with ivermectin (200 lg ⁄ kg in a single oral dose)
was proposed for all culture-positive patients and, regardless
of the culture result, for all patients with an indirect immuno-
fluorescence test positive at a dilution > 1:80.
Data analysis
Statistical analysis was performed with the BMDP New
System v.2.0 software package (Statistical Solutions, Cork,
Ireland). For continuous variables, distribution of data was
checked for normality by Shapiro and Wilk’s W-tests. When
not departing significantly from the normal distribution, data
were analysed by parametric methods (Student’s t-test) and
the variations observed among groups were calculated as
means ± SD; otherwise, data were analysed by non-parametric
methods (Mann–Whitney test; Spearman rank correlation
coefficient) and the variations among groups were calculated
as medians (range). Associations among categorical variables
were analysed by Pearson’s chi-square test and presented as
observed frequencies and proportions. The probabilities of
finding the outcome of interest (i.e., a positive test for anti-
Strongyloides antibodies) were calculated in relationship to the
characteristic defining cases and controls (i.e., the eosinophil
count) and to several variables of interest as ORs (with
95% CIs calculated according to Woolf’s logit-based formula)
[9]. Mantel–Haenszel statistics were used to measure the
common risk for both cases and controls of having positive
anti-Strongyloides antibodies in the presence of a history of
farm work. The confounding effect of multiple variables on the
characteristic defining cases and controls (i.e., the eosinophil
count) was calculated by stepwise logistic regression for a
case-control study. The area under the receiver operating
characteristic (ROC) curve was calculated to assess the
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performance of the eosinophil count as a diagnostic test of
strongyloidiasis in the study population [10]. For all tests, the
level chosen to indicate statistical significance was p < 0.05
(two-tailed).
RESULTS
The study population comprised 118 male and 82
female patients, admitted to 22 different hospital
wards. The two groups were well-matched in
terms of demographical and biohumoral variables
(Table 1). Skin lesions and respiratory symptoms
were significantly more common among group A
patients (Table 2). The skin lesions comprised
urticaria (six group A and six group B patients),
maculo-papular rash (three group A and three
group B patients), erythema (diffuse: six group A
and two group B patients; localised: five
group A and five group B patients), eczema (five
groupA patients), localised pustules (two group A
patients), herpes zoster (three group A and two
group B patients) and other miscellaneous lesions
(one erysipelas, one non-specific dermatitis and
one vitiligo in group A; one purpura and one
non-specific dermatitis in group B). None of the
patients had skin manifestations pathognomonic
of infection with S. stercoralis (e.g., larva currens).
Fig. 1 presents the scatter-plot of the individual
titres of anti-Strongyloides antibodies in the two
groups. Seropositivity for anti-Strongyloides anti-
bodies at a titre > 1:80 was found more often in
group A (9 ⁄ 100) than in group B (2 ⁄ 100) patients
(OR 4.85, 95% CI 1.02–23.05, p 0.030). A history
of farm work was associated strongly with sero-
positivity for anti-Strongyloides antibodies; thus,
among 87 patients who had worked on farms,
either continuously or occasionally, 11 were sero-
positive. None of the remaining 113 patients with
no history of farm work had anti-Strongyloides
antibodies (OR not measurable; p < 0.001). The
strength of this association was confirmed in both
group A and group B patients (Mantel–Haenszel
test, average risk 5.97, p < 0.001).
A correlation existed between the eosinophil
count and the anti-Strongyloides titre (Spearman
correlation coefficient, r 0.191, p 0.007). This cor-
relation was caused entirely by the subgroup of
patients with a history of farm work (n = 87,
Spearman correlation coefficient, r 0.389,
p < 0.005), and was not found with the remaining
patients (n = 113, Spearman correlation coeffi-
cient, r ) 0.043, p 0.649). The two seropositive
patients in group B had an eosinophil count of
0.3 · 109 ⁄L, which was thee times the median
value for this variable in group B. The area under
the ROC curve of the eosinophil count for dis-
criminating patients with an anti-Strongyloides
titre > 1:80 was 0.829, with an optimal cut-off
value of 0.7 · 109 ⁄L.
Table 1. Selected demographical and clinical characteris-
tics of the population studied
Characteristic
Group A
(n = 100)
Group B
(n = 100) p
Female gender 41 41 1.000a
Age, years 74.3 ± 7.7 74.6 ± 7.6 0.774b
Body mass index, kg ⁄m2 24.9 ± 4.1 24.7 ± 4.0 0.737b
Farm work 47 40 0.318a
Work in rice fields 24 16 0.157a
Travel abroad 24 34 0.119a
BUN, mg ⁄dL 18 (3–138) 19 (3–117) 0.585c
AST, U ⁄L 20 (5–240) 23 (4–252) 0.181c
Eosinophil count, · 109 ⁄L 0.7 (0.6–3.9) 0.1 (0.0–0.4) < 0.001c
aPearson chi-square test.
bStudent’s t-test.
cMann–Whitney test.
BUN, blood urea nitrogen; AST, aspartate aminotransferase.
Table 2. Number of patients showing signs and symp-
toms compatible with strongyloidiasis in the population
studied
Signs and symptoms
Group A
(n = 100)
Group B
(n = 100) OR (95% CI) pa
Pruritus 30 27 1.16 (0.63–2.14) 0.638
Skin lesions 33 20 1.97 (1.04–3.75) 0.037
Recurrent abdominal pain 35 46 0.63 (0.36–1.11) 0.113
Diarrhoea 29 19 1.74 (0.90–3.37) 0.098
Respiratory symptoms 47 13 5.93 (2.94–11.97) < 0.001
aPearson chi-square test.
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Fig. 1. Scatter-plot of individual anti-Strongyloides anti-
body titres in patients with elevated (group A) and normal
(group B) peripheral eosinophil concentrations.
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There was no significant association between
seropositivity for anti-Strongyloides antibody and
work in rice fields, a lengthy residence abroad, or
the presence of pruritus, skin lesions, diarrhoea,
recurrent abdominal pain or respiratory symp-
toms (p > 0.10 for each). Following multivariate
analysis, the variables associated independently
with group A (eosinophilia) were the presence of
respiratory symptoms (p < 0.001), abdominal
pain (p 0.021), seropositivity for anti-Strongyloides
antibodies (p 0.031) and skin lesions (p 0.047)
(goodness of fit chi-square = 94.8, p 0.514).
Within 6 months of the indirect immunofluo-
rescence assay being performed, all 28 patients
with a positive test, of any titre, were traced. Of
these 28 patients, 13 had died, with the causes of
death, deduced from the death certificates, being
gastrointestinal tumours (n = 2), other tumours
(n = 4), acute myocardial infarction (n = 2), heart
failure (n = 2), stroke (n = 2) and aspiration
pneumonia (n = 1). Among the 15 surviving
patients, two had been diagnosed with strongylo-
idiasis by their physicians and had received
appropriate treatment. One had diagnostic histol-
ogy following gastrectomy, performed for causes
unrelated to strongyloidiasis (gastric cancer); the
other had been offered empirical anti-helminthic
treatment by his physician, once notified of the
serological test result, before stool cultures could
be performed. The remaining 13 patients were
invited to provide three fresh stool samples, on
three separate days. Among the 39 specimens,
three (8%) from two patients were positive. These
two patients, as well as three other patients whose
stool cultures were negative but who were sero-
logically positive at titres ranging from 1:160 to
1:1280, were treated with oral ivermectin.
DISCUSSION
The present study revealed that the number of
elderly in-patients living in a rural area in
northern Italy with serological evidence of an
immune response to S. stercoralis was substantial,
reflecting the endemicity of the disease in this
area [7,8]. When a patient has lived in or travelled
to areas where S. stercoralis infection is endemic,
and presents with compatible skin, respiratory or
gastrointestinal symptoms [4], strongyloidiasis
is an obvious diagnostic possibility. However,
the parasite is capable of auto-infection of its host.
A chronic well-regulated infection can remain
virtually asymptomatic and be sustained almost
indefinitely, or at least until host-cell-mediated
immunity fails [11,12]. Therefore, a primary infec-
tion may have occurred up to six decades earlier,
i.e., when living conditions in industrialised
countries were much more similar to those in
developing countries today.
To diagnose such cases, in the absence of
updated epidemiological data, it is crucial to
identify the patients at risk, and to establish how
they should be tested. With regard to the first
point, the present study indicated clearly that
relying on symptoms in order to select a popu-
lation with a high likelihood a priori of a positive
test result would not constitute an effective
strategy. In contrast, it suggests that addressing
two simple questions (i.e., is there a history of
farm work, and what is the eosinophil count?)
may enable the clinician to limit the number of
patients who need to be screened. The concept
that a history of farm work and the presence of an
elevated eosinophil count have value in the
diagnosis of strongyloidiasis is not novel [13–
16], but validation in a prospective, case-control
study has not, to our knowledge, been performed
previously. Farm work is thought to facilitate
transmission of the parasite through direct con-
tact with soil, in particular by working barefoot
and by ingestion of contaminated non-potable
water. It has also been known for many years that
an elevation of the eosinophil count may alert the
clinician to the possibility of parasitic disease.
Eosinophilia is a relatively rare condition that,
among outpatients, is related mostly to atopy [17],
but is likely in the present setting to be the result
of a Th2-type response to helminth antigens,
causing increased production of eosinophil
growth factors, particularly interleukin-5 [18,19].
As shown by the present data, eosinophilia
among elderly in-patients can be attributed to
respiratory and ⁄ or skin disorders, and is not
indicative per se of strongyloidiasis. Moreover, the
exact threshold level of the eosinophil count that
should be used to define eosinophilia also
remains undefined. The normal concentration of
peripheral blood eosinophils is 0.015–0.65 · 109 ⁄L
[20], with a diurnal variability [21], but a concen-
tration of 0.5–1.5 · 109 ⁄L is considered by many
to represent mild eosinophilia [22], whereas, for
others, the upper limit of the normal range is
0.35 · 109 ⁄L [23]. White blood cell counts of
elderly individuals do not differ from those of
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young adults [24]. Nevertheless, it may help
clinicians to know that, in the trade-off between
sensitivity and specificity, the best cut-off value
for considering a diagnosis of S. stercoralis infec-
tion on the basis of the eosinophil count would be
0.7 · 109 ⁄L.
Laboratory diagnosis of S. stercoralis infection is
difficult to establish. Direct methods for isolation
of the parasite are time-consuming, insensitive
and costly, mainly because the intestinal worm
load in uncomplicated infections is often very low
and the output of larvae is minimal [2]. Thus,
serological tests have been advocated because
they are easier to perform and offer superior
sensitivity [25]. However, in comparison with
direct methods for parasite isolation, serological
tests do not allow a distinction between past and
current infection, and have inferior specificity
because of cross-reactivity with other helminth
infections. Nevertheless, where the prevalence of
strongyloidiasis is supposedly high, the positive
predictive value of serological tests is increased.
Furthermore, although the indirect immunofluo-
rescence test was very efficient in the present
study, a standardised ELISA, with a reported
sensitivity and specificity of > 90%, may be
preferred by others [26]. A cost-effective approach
in endemic areas (including central, eastern and
southern Europe) would be to use serological and
cultural tests in sequence, i.e., to screen patients at
risk with a serological test and, in the event of a
positive result, to confirm the diagnosis by means
of faecal cultures. However, since oral ivermectin,
the treatment suggested currently for uncompli-
cated strongyloidiasis, is relatively inexpensive,
effective and well-tolerated by most patients
[27,28], it may also be reasonable to treat all
patients with a high titre of anti-Strongyloides
antibodies, regardless of the results of culture.
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